MedTrace Logo

Clinical Performance of Two Commercial, Daily Disposable Contact Lenses

NCT05010512 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2022-11-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the clinical performance of DAILIES TOTAL1 ( DT1) contact lenses with Infuse contact lenses.

Conditions

  • Refractive Errors
  • Ametropia
  • Myopia

Interventions

DEVICE

Delefilcon A contact lenses

Commercially available silicone hydrogel contact lenses used as indicated

DEVICE

Kalifilcon A contact lenses

Commercially available silicone hydrogel contact lenses used as indicated

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Lead, Vision Care · Alcon Research, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2021-10-12
Completion
2021-10-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05010512 on ClinicalTrials.gov